Medigrowth Australia
PrivateLast Round
Early Funding
Mar 13, 2025
Total Funding Raised
$3.25M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Medigrowth Australia is a biotechnology company that manufactures and supplies medicinal cannabis products and conducts clinical research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Telemedicine, Clinical Trials, Drug Discovery
Business Model
B2B2C
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medigrowth Australia Comparables
Compare Medigrowth Australia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medcan Australia | 86% | |
| Australian Natural Therapeutics Group | 83% | |
| Bod Science | 82% |
Medigrowth Australia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 13, 2025 | ||||
| Crowdfunding | Aug 31, 2023 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 70% MoM.
- Jun 8, 2026
Grew 33% QoQ, from 9 to 12 employees.
Medigrowth Australia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Medigrowth Australia's valuation, stock price, and market status.
Is Medigrowth Australia a public or private company?
Medigrowth Australia is a private company.
What is the current stock price of Medigrowth Australia?
Medigrowth Australia is a private company with no public stock price. No recent secondary market data is available.
How much is Medigrowth Australia worth (valuation)?
Valuation information for Medigrowth Australia is not publicly available.
Can I buy Medigrowth Australia stock?
Medigrowth Australia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Medigrowth Australia's last funding round?
Medigrowth Australia's most recent funding round was Early Funding on March 13, 2025.
Who are the main investors in Medigrowth Australia?
Investor information for Medigrowth Australia is not publicly disclosed.
Will Medigrowth Australia IPO soon?
No public IPO plans have been announced for Medigrowth Australia.
How can I track Medigrowth Australia secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Medigrowth Australia's secondary market activity and sign up for updates.